Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 41

1.

Protective effects of vitamin D3 on fimbrial cells exposed to catalytic iron damage.

Uberti F, Morsanuto V, Lattuada D, Colciaghi B, Cochis A, Bulfoni A, Colombo P, Bolis G, Molinari C.

J Ovarian Res. 2016 Jun 17;9(1):34. doi: 10.1186/s13048-016-0243-x.

2.

The role of geographical ecological studies in identifying diseases linked to UVB exposure and/or vitamin D.

Grant WB.

Dermatoendocrinol. 2016 Jan 8;8(1):e1137400. doi: 10.1080/19381980.2015.1137400. eCollection 2016 Jan-Dec. Review.

3.

Micronutrients in Oncological Intervention.

Gröber U, Holzhauer P, Kisters K, Holick MF, Adamietz IA.

Nutrients. 2016 Mar 12;8(3):163. doi: 10.3390/nu8030163. Review.

4.

TROP-1/Ep-CAM and CD24 are potential candidates for ovarian cancer therapy.

Wang G, Zhang Z, Ren Y.

Int J Clin Exp Pathol. 2015 May 1;8(5):4705-14. eCollection 2015.

5.

Evidence of differential effects of vitamin d receptor variants on epithelial ovarian cancer risk by predicted vitamin d status.

Prescott J, Bertrand KA, Reid BM, Permuth-Wey J, De Vivo I, Cramer DW, Terry KL, Tworoger SS.

Front Oncol. 2014 Oct 20;4:286. doi: 10.3389/fonc.2014.00286. eCollection 2014.

6.

A phase I study to determine the maximum tolerated dose and safety of oral LR-103 (1α,24(S)Dihydroxyvitamin D2) in patients with advanced cancer.

Wisinski KB, Ledesma WM, Kolesar J, Wilding G, Liu G, Douglas J, Traynor AM, Albertini M, Mulkerin D, Bailey HH.

J Oncol Pharm Pract. 2015 Dec;21(6):416-24. doi: 10.1177/1078155214541572. Epub 2014 Jul 1.

7.

Vitamin D: Update 2013: From rickets prophylaxis to general preventive healthcare.

Gröber U, Spitz J, Reichrath J, Kisters K, Holick MF.

Dermatoendocrinol. 2013 Jun 1;5(3):331-47. doi: 10.4161/derm.26738. Epub 2013 Nov 5. Review.

8.

Sunlight and Vitamin D: A global perspective for health.

Wacker M, Holick MF.

Dermatoendocrinol. 2013 Jan 1;5(1):51-108. doi: 10.4161/derm.24494. Review.

9.

Surrogates of long-term vitamin d exposure and ovarian cancer risk in two prospective cohort studies.

Prescott J, Bertrand KA, Poole EM, Rosner BA, Tworoger SS.

Cancers (Basel). 2013 Nov 22;5(4):1577-600. doi: 10.3390/cancers5041577.

10.

Molecular link between vitamin D and cancer prevention.

Moukayed M, Grant WB.

Nutrients. 2013 Sep 30;5(10):3993-4021. doi: 10.3390/nu5103993. Review.

11.

Vitamin D and VDR gene polymorphism (FokI) in epithelial ovarian cancer in Indian population.

Mohapatra S, Saxena A, Gandhi G, Koner BC, Ray PC.

J Ovarian Res. 2013 May 26;6(1):37. doi: 10.1186/1757-2215-6-37.

12.

Common variants of the vitamin D binding protein gene and adverse health outcomes.

Malik S, Fu L, Juras DJ, Karmali M, Wong BY, Gozdzik A, Cole DE.

Crit Rev Clin Lab Sci. 2013 Jan-Feb;50(1):1-22. doi: 10.3109/10408363.2012.750262. Epub 2013 Feb 22. Review.

13.

A randomized trial of vitamin D supplementation in 2 community health center networks in South Carolina.

Wagner CL, McNeil R, Hamilton SA, Winkler J, Rodriguez Cook C, Warner G, Bivens B, Davis DJ, Smith PG, Murphy M, Shary JR, Hollis BW.

Am J Obstet Gynecol. 2013 Feb;208(2):137.e1-13. doi: 10.1016/j.ajog.2012.10.888. Epub 2012 Nov 3.

14.

Sun exposure and risk of epithelial ovarian cancer.

Bodelon C, Cushing-Haugen KL, Wicklund KG, Doherty JA, Rossing MA.

Cancer Causes Control. 2012 Dec;23(12):1985-94. doi: 10.1007/s10552-012-0076-x. Epub 2012 Oct 12.

15.

Vitamin D-insufficiency: An estimate of the situation in Germany.

Ringe JD, Kipshoven C.

Dermatoendocrinol. 2012 Jan 1;4(1):72-80. doi: 10.4161/derm.19829.

16.

Vitamin D and its role during pregnancy in attaining optimal health of mother and fetus.

Wagner CL, Taylor SN, Dawodu A, Johnson DD, Hollis BW.

Nutrients. 2012 Mar;4(3):208-30. doi: 10.3390/nu4030208. Epub 2012 Mar 21. Review.

17.

The role of vitamin D in pregnancy and lactation: emerging concepts.

Wagner CL, Taylor SN, Johnson DD, Hollis BW.

Womens Health (Lond Engl). 2012 May;8(3):323-40. doi: 10.2217/whe.12.17. Review.

18.

Vitamin D3 supplementation at 4000 international units per day for one year results in a decrease of positive cores at repeat biopsy in subjects with low-risk prostate cancer under active surveillance.

Marshall DT, Savage SJ, Garrett-Mayer E, Keane TE, Hollis BW, Horst RL, Ambrose LH, Kindy MS, Gattoni-Celli S.

J Clin Endocrinol Metab. 2012 Jul;97(7):2315-24. doi: 10.1210/jc.2012-1451. Epub 2012 Apr 16.

19.

Systems biology-based analysis implicates a novel role for vitamin D metabolism in the pathogenesis of age-related macular degeneration.

Morrison MA, Silveira AC, Huynh N, Jun G, Smith SE, Zacharaki F, Sato H, Loomis S, Andreoli MT, Adams SM, Radeke MJ, Jelcick AS, Yuan Y, Tsiloulis AN, Chatzoulis DZ, Silvestri G, Kotoula MG, Tsironi EE, Hollis BW, Chen R, Haider NB, Miller JW, Farrer LA, Hageman GS, Kim IK, Schaumberg DA, DeAngelis MM.

Hum Genomics. 2011 Oct;5(6):538-68.

20.

Cataract and ovarian carcinoma: is the vitamin D hypothesis alive?

Lurie G, Matsuno RK, Wilkens LR, Thompson PJ, Ollberding NJ, Carney ME, Goodman MT.

Cancer Epidemiol Biomarkers Prev. 2011 Dec;20(12):2507-11. doi: 10.1158/1055-9965.EPI-11-0721. Epub 2011 Oct 5.

Items per page

Supplemental Content

Write to the Help Desk